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Abstract: The aim of this systematic review is to evaluate the role of enteral nutrition in 
managing patients with diabetes on enteral feed. The prevalence of diabetes is on the increase 
in the UK and globally partly due to lack of physical activities, poor dietary regimes and 
genetic susceptibility. The development of diabetes often leads to complications such as 
stroke, which may require enteral nutritional support. The provision of enteral feeds comes 
with its complications including hyperglycaemia which if not managed can have profound 
consequences for the patients in terms of clinical outcomes. Therefore, it is essential to 
develop strategies for managing patients with diabetes on enteral feed with respect to the 
type and composition of the feed. This is a systematic review of published peer reviewed 
articles. EBSCOhost Research, PubMed and SwetsWise databases were searched. Reference 
lists of identified articles were reviewed. Randomised controlled trials comparing enteral 
nutrition diabetes specific formulas with standard formulas were included. The studies which 
compared diabetes specific formulas (DSF) with standard formulas showed that DSF was 
more effective in controlling glucose profiles including postprandial glucose, HbA1c and 
insulinemic response. The use of DSF appears to be effective in managing patients with 
diabetes on enteral feed compared with standard feed. 
Keywords: enteral nutrition; diabetes; diabetes specific formula; standard formula; 
hyperglycaemia; glycaemic index 
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1. Introduction 
The prevalence of diabetes and the cost to the National Health Service (NHS) have been on the 
increase in the UK [1,2]. Various factors including the failure to maintain a healthy lifestyle such as 
regular physical activity and healthy dietary regimes, and genetic susceptibility have been ascribed as 
possible reasons for the high incidence of the condition [3,4]. The manifestation of diabetes comes with 
various complications such as cerebrovascular accident, which may result in dysphagia, often requiring 
nutritional support [5,6]. This is especially evident in patients with diabetes who may be unable to 
maintain their nutritional requirements through the use of oral dietary intake alone and thus may require 
enteral feed. In addition, their involvement in physical activity that would ensure the maintenance of 
normal glucose levels may be compromised due to their neurological conditions and poor mobility [7,8]. 
Therefore, managing a person with diabetes on enteral nutrition could present some difficulties for the 
multidisciplinary healthcare professional (HCP) team if there are no effective strategies for managing 
the enteral feed [9]. There could be increased risk of the patient with diabetes on enteral feed developing 
hyperglycaemia or hypoglycaemia, which can result in potentially poorer clinical outcomes [10–12]. 
In a study by Ojo [13], comparison of patients on home enteral tube feeding (HETF) with the Quality 
and Outcome Framework (QOF) data revealed that diabetes prevalence in people on HEFT in Lambeth, 
Lewisham and Southwark primary care trusts in the UK was significantly higher (7.78%) than in the 
general population (3.63%) not on enteral nutrition and living in the same area. Ojo [13] showed that 
more patients who have diabetes are now requiring enteral nutrition support. 
The role of enteral nutrition in patients with diabetes is to provide the required macro- and  
micro-nutrients including energy, protein, vitamins and minerals in part or whole in order to reduce the 
risk of malnutrition in these patients [14]. However, due to the nature of the different food formulas, the 
risk of hyperglycemia could be a major challenge in these patients and newly diagnosed hyperglycaemia 
could be considered an independent prognostic factor of mortality in patients with enteral feeding [15,16]. 
Hyperglycaemia can have profound impacts on a range of patients with diabetes including those 
hospitalised, such as patients with diabetic ulcers or undergoing limb amputations. Hyperglycemia may 
impact on wound healing, time spent in hospital and lead to complications including diabetic 
ketoacidosis and hyperosmolar non-ketotic state [17,18]. Therefore, there is the need to ensure adequate 
management of patients with diabetes, especially those on enteral feed because of the effects on blood 
glucose levels. The cost of major complications resulting from hyperglycaemia to the UK economy has 
been estimated to be between £872 for blindness in one eye to £8459 for amputation per patient, although 
the total cost of type 2 diabetes to the UK economy appears difficult to evaluate [19]. However, in 2007 
estimates of 7%–12% of the total NHS budget, which could be £2.8 billion associated cost for the UK 
has been reported [1,20]. 
Nutritional requirements of patients with diabetes on enteral nutrition are met with the use of standard 
enteral feeds or diabetes specific feeds. Diabetes specific formulas contain specific ingredients that often 
include fructose and a large amount of monounsaturated fatty acids, which are aimed at controlling 
postprandial glucose [21,22]. The effects of these feeds in maintaining the nutritional requirements and 
physiological state of patients with diabetes continue to generate debate and attract the interest of 
researchers. A scoping exercise of the literature revealed two systematic reviews on the role of enteral 
nutritional support and the use of diabetes specific formulas for patients with diabetes carried out at 
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various times with different findings [19]. A systematic review and meta-analysis of enteral nutritional 
support and use of diabetes specific formulas conducted by Elia et al. [19] aimed to determine the 
benefits of nutritional support in patients with types 1 and 2 diabetes. It compared the use of nutritional 
support with routine care, and standard formulas with diabetes formulas. Although the study concluded 
that the use of diabetes specific formulas (DSF) as oral nutrition supplements and tube feeds improve 
blood glucose levels when compared with standard formulas, controversies still surround the use of DSF. 
In particular, there are clinical interests in establishing the safety and tolerance of relatively high levels 
of fat and fructose in patients with underlying dysmotility disorders such as irritable bowel syndrome 
and with respect to lipid metabolism and lactic acidosis [22]. Since the study by Elia et al. [19], a number 
of randomised controlled trials based on patients with diabetes on enteral nutrition have been published. 
In addition, the American Society of Parenteral and Enteral Nutrition (ASPEN) Clinical Guidelines: 
nutrition support of adult patients with hyperglycaemia which was developed in order to provide the 
desired blood glucose goal in hospitalized patients receiving nutritional support could not recommend 
whether diabetes specific formulas can be used for hospitalised adult patients with hyperglycaemia [23]. 
The ASPEN Clinical Guidelines recommendation for the use of diabetes specific formula was based 
on only two studies published in 2003 and 2005. It was therefore not surprising that the ASPEN guideline 
recommended that further research was required in the use of diabetic specific formulas [23]. According 
to Cheng [24], two strategies for managing hyperglycaemia of enteral feeding are adjustment of the 
enteral feed carbohydrate content and pharmacological therapy to lower glucose levels although the 
current review is focused on the former. 
Drawing from the above reviews and guidelines, the need to examine the role of standard versus 
diabetes specific formulas has become pertinent. Therefore, the aim of the present study is to carry out 
a systematic review of the role of enteral nutrition in supporting patients with diabetes. However, the 
use of insulin and oral hypoglycaemic agents was not examined in this review. 
The objective is as follows:  
• To examine the effects of standard and diabetes specific enteral formulas in the management  
of diabetes. 
The research question is: 
• Is diabetes specific formula more effective than standard formulas in managing patients with 
diabetes on enteral feed? 
2. Experimental Section 
A systematic review was carried out based on published guidelines [25,26]. This involved a literature 
search of articles of interest relating to the use of enteral nutrition in diabetes management, including a 
general scoping of the data bases which found only two systematic reviews that were relevant to the 
population and intervention of interest. A search of the Cochraine library and databases of abstracts of 
reviews and effects found one article by Elia et al. [19], which was published in 2005. A further search 
of SwetsWise and EBSCO host databases found the ASPEN guidelines; nutrition support of adult 
patients with hyperglycaemia [23]. Although this guideline was published in 2013, it derived most of its 
limited evidence with respect to the question on the use of diabetes specific formulas in adult hospitalised 
patients with hyperglycaemia from studies published between 2003 and 2005. 
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The research question was defined into the component parts; the Population (P), the Interventions (I), 
Comparative interventions (C) and Outcomes (O) based on PICO framework [25]. Table 1 shows the 
results of the various searches. The databases searched included EBSCO Host/Health Sciences Research 
databases (encompassing Academic search premier, Medline, Psychology and Behavioural sciences 
collection, PSYCINFO, SPORTDISCUSS and Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) Plus) and SwetsWise. The reference list of relevant systematic reviews and articles 
were checked in order to identify studies that could be useful to the present review. 
Table 1. Literature search strategy. 
Database 
Dates 
Covered 
Date 
Searched 
Hits Search Terms 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 469,184 Diabetes 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 323 Diabetes and Enteral Nutrition 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 13 
Diabetes and Enteral Nutrition 
and Diabetes Specific formula 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 2 
Diabetes and Enteral Nutrition  
and Standard Feed 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 1 
Diabetes and Enteral Nutrition  
and Glycated Haemoglobin 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 4 
Diabetes and Enteral Nutrition  
and Fasting Blood Glucose 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 28 
Diabetes and Enteral Nutrition  
and Hyperglycaemia 
EBSCO Host (Health Sciences 
Research Databases) 2005–2014 04.06.14 11 
Diabetes and Enteral Nutrition 
and Hypoglycaemia 
SwetsWise 2005–2014 04.06.14 46 Diabetes and Enteral Nutrition 
SwetsWise 2005–2014 04.06.14 47 Diabetes and Standard feed 
SwetsWise 2005–2014 04.06.14 73 
Diabetes and Diabetes  
Specific feed 
2.1. Inclusion and Exclusion Criteria 
Only randomised controlled trials were selected for inclusion in the current review. 
The participants in the studies included in the systematic review were adult males and females who 
had diabetes and were on enteral nutrition while the interventions were standard enteral feed and DSF. 
The outcome measures included in the search were; HbA1c, fasting blood glucose, hyperglycaemia 
and hypoglycaemia. 
In terms of the years of publication, searches were conducted between 2005 and 2014 while only 
studies written in English language were included. Studies that did not meet the above inclusion criteria 
were excluded from the study. 
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2.2. Data Analysis 
Based on the criteria outlined for exclusion and inclusion of various studies, 469,184 articles were 
initially available. This number was further reduced to 323 articles with the inclusion of enteral nutrition 
as part of the search term (Table 1). Of these articles, five articles that met the requirements for selection 
were included in the review (Table 2). 
3. Results 
All the studies included in the systematic review involved patients who had type 2 diabetes and these 
were clearly specified in the method section in the respective studies. While three studies compared DSF 
with standard formula [21,27,28], one study [29] compared slowly digested carbohydrate formula with 
DSF and standard formula (Table 2). The final study compared diabetes specific enteral formula with 
49.95% calories provided by fat and diabetes specific enteral formula with 34% calories provided by  
fat [30]. 
In the study by Ceriello et al. [21], glucose profiles were significantly better after administering DSF 
compared with standard formula. In addition, diabetes specific formula significantly improved 
postprandial glucose compared with the standard, fibre-containing formula. 
With respect to the study by Vaisman et al. [28], HbA1c decreased over time in the diabetes specific 
diet group and increased in the standard feed group. Similarly, in the randomised double-blinded study 
evaluating the postprandial glycaemic and insulinemic response conducted by Alish et al. [27], 
differences in adjusted peak plasma glucose levels were significantly lower in DSF compared with 
standard formulas (STF) (p < 0.001). In addition, differences in adjusted peak insulin levels were 
significantly lower in DSF compared with STF (p = 0.017). In other words, the use of DSF produced 
significantly lower postprandial and insulinemic response. 
Voss [29] revealed that adjusted glucose concentrations were significantly higher at all points after 
feeding the STF compared with the slowly digested carbohydrate formula (SDC) or DSF (p < 0.001). In 
addition, adjusted plasma glucose concentrations for the SDC were observed to be significantly lower 
than those for the DSF from 30 to 120 min (p < 0.05). In relation to the adjusted insulin responses, these 
were significantly higher for the STF compared with the SDC at each time point, while the SDC had a 
significantly lower insulinemic response compared with the DSF at 90 and 120 min (p < 0.05) [29]. 
Finally, the adjusted results for postprandial glucagon-like polypeptide-1 (GLP-1) levels at 30 and  
60 min in this study were significantly lower for the STF compared with SDC (p < 0.05), but not different 
from the DSF [29]. 
In the study by De Luis et al. [30] which compared diabetes specific enteral supplement with 49.95% 
calories provided by fat (Gp 1) and diabetes specific enteral supplement with 34% calories provided by 
fat (Gp 2), a significant decrease of glucose and HbA1c was observed in Gp 1 compared with Gp 2. 
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Table 2. Summary of studies reviewed.  
Citation Study Type 
Population and 
Sample Size 
Age (Years) Intervention Outcomes Remarks 
Ceriello A  
et al., 2009 
[21] 
Randomized 
Controlled Study 
12 67.2 ± 1.3 
Diabetes-Specific Formula 
(DSF) 
Standard Formula (STF) 
Fasting Glucose (mmol/L) = 7.9 ± 0.45  
24 h Glucose Concentrate  
(mmol/L-SEM) = 8.7 ± 0.5  
Day time = 9.4 ± 0.6  
Fasting Glucose (mmol/L) = 7.6 ± 0.37  
24 h Glucose Conc. (mmol/L-SEM) = 9.6 ± 0.6 
Day time = 10.7 ± 0.6 
Results are 
expressed as  
mean ± SEM 
Voss AC,  
2008 [29] 
Randomized 
Controlled Study 
48 
56 ± 1.4 
(SEM) 
Slowly Digested Carbohydrate 
Formula (SDC) 
DSF  
STF 
The positive area under the curve for glucose 
and insulin with STF was higher (p < 0.001) 
compared with the SDC and DSF. The adjusted 
Glucagon-like peptide-1 (GLP-1) concentration 
at 60 min. was higher for the SDC compared 
with the DSF and STF (p < 0.05). 
Results are 
expressed as  
mean ± SEM 
De Luis et al., 
2008 [30] 
Randomized  
Clinical Trial 
16 
14 
74.6 ± 7.1 
77.1 ± 8.7 
Diabetes Specific Enteral 
Formula (49.95% of Calories 
provided by fat, Gp 1) 
Diabetes Specific Enteral 
Formula (34% of Calories 
provided by fat, Gp 2) 
Baseline Glucose mg/dL = 119.8 ± 42  
10 weeks = 95.1 ± 16.8 HbA1c% = 8.2 ± 2.8  
at baseline, 5.8 ± 0.7% at 10 weeks  
Baseline Glucose mg/dL = 122.4 ± 22.8  
10 weeks = 130.6 ± 41.4  
Baseline HbA1c% = 7.58 ± 1.7  
10 weeks = 7.38 ± 1.5 
Results are 
expressed as  
mean ± SD 
Vaisman et al., 
2009 [28] 
Randomized 
Controlled Trial 
13 
12 
79.2 ± 10.4 
(Mean ± SD)  
73.0 ± 14.7  
(Mean ± SD) 
Standard tube feed 
Diabetes Specific Tube feed 
HbA1c = 7.9 ± 0.3% at baseline,  
8.7 ± 0.4% at 12 weeks  
HbA1c = 6.9 ± 0.3% at baseline,  
6.2 ± 0.4% at 12 weeks 
Results are 
expressed as  
mean ± SEM 
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Table 2. Cont. 
Citation Study Type 
Population and 
Sample Size 
Age (Years) Intervention Outcomes Remarks 
Alish CJ et al., 
2010 [27] 
Randomized, 
double blinded 
crossover design  
(Postprandial 
glycaemic and 
Insulinemic 
response) 
22 63.1 ± 1.9 
DSFs 
STFs 
Baseline plasma Glucose = 113.1 ± 6.9 mg/dL  
Adjusted (change from baseline) plasma glucose 
conc. = 22.3 ± 4.4 mg/dL  
Baseline insulin levels = 21.2 ± 2.9 μL/mL  
Peak insulin levels = 79.5 ± 17.2 μL/mL 
Baseline plasma Glucose = 124.8 ± 5.3 mg/dL  
Adjusted (change from baseline) plasma glucose 
conc. = 71.1 ± 7.0 mg/dL  
Baseline insulin levels = 16.3 ± 1.7 μL/mL  
Peak insulin levels = 115.2 ± 28.0 μL/mL 
Results are 
expressed as  
mean ± SEM 
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With respect to the study by Vaisman et al. [28], HbA1c decreased over time in the diabetes specific 
diet group and increased in the standard feed group. Similarly, in the randomised double-blinded study 
evaluating the postprandial glycaemic and insulinemic response conducted by Alish et al. [27], 
differences in adjusted peak plasma glucose levels were significantly lower in DSF compared with STF 
(p < 0.001). In addition, differences in adjusted peak insulin levels were significantly lower in DSF 
compared with STF (p = 0.017). In other words, the use of DSF produced significantly lower 
postprandial and insulinemic response. 
Voss [29] revealed that adjusted glucose concentrations were significantly higher at all points after 
feeding the STF compared with the SDC or DSF (p < 0.001). In addition, adjusted plasma glucose 
concentrations for the SDC were observed to be significantly lower than those for the DSF from 30 to 
120 min (p < 0.05). In relation to the adjusted insulin responses, these were significantly higher for the 
STF compared with the SDC at each time point, while the SDC had a significantly lower insulinemic 
response compared with the DSF at 90 and 120 min (p < 0.05) [29]. Finally, the adjusted results for 
postprandial GLP-1 levels at 30 and 60 min in this study were significantly lower for the STF compared 
with SDC (p < 0.05), but not different from the DSF [29]. 
In the study by De Luis et al. [30] which compared diabetes specific enteral supplement with 49.95% 
calories provided by fat (Gp 1) and diabetes specific enteral supplement with 34% calories provided by 
fat (Gp 2), a significant decrease of glucose and HbA1c was observed in Gp 1 compared with Gp 2. 
4. Discussion 
Diabetes specific formula seems to be effective in managing glucose profiles including postprandial 
glucose and insulinemic response and HbA1c compared with standard formula in patients with diabetes 
on enteral nutrition. The effectiveness of DSF in patients with diabetes on enteral feed may be partly due 
to the form of carbohydrate used in its formulation. Diabetes specific formulas often contain 
carbohydrate that are more slowly digested and absorbed compared with standard formula that contain 
carbohydrates that are more rapidly digested and absorbed [27]. Postprandial blood glucose response, 
which is a risk factor for micro- and macro-vascular complications, has been shown to be influenced 
profoundly by the specific composition of the diet [31]. The measure of how soon glucose reaches the 
blood stream is often termed the glycaemic index (GI) of food while the glycaemic load (GL) shows the 
overall glycaemic effect of a specific amount of food item [1]. It is possible that DSFs are formulated 
with carbohydrates which have lower GI compared with standard formulas. In a study conducted by 
Hofman et al. [32], it was shown that the GI of the 12 enteral formulas determined in the study varied 
widely from GI = 12 for a diabetes specific feed up to GI = 61 for a standard supplement. High GI foods 
have GI value ≥70 while medium GI values range from 55 to 70 compared to low GI foods that have GI 
value ≤55 [33]. According to Hofman et al. [32], in general, a low GI formula (DSF) is characterised by 
reduced carbohydrate content, presence of fructose, a higher fat content containing monounsaturated 
fatty acids (MUFA) and high amounts of fibre while standard formulas, especially sip feeds, often do 
not contain fibre. This view is reinforced by Charney and Hertzler [34] who noted that diets containing 
up to 30% of total calories as MUFA have led to improvements in lipoprotein levels and glycaemic 
control in patients with diabetes. In addition, small doses of fructose (5 g to 10 g) have been found to be 
effective in reducing acute glycaemic response to a carbohydrate challenge partly because of the low GI 
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of fructose, which is 19 compared with the GI of glucose which is 100 [34]. On the other hand, standard 
enteral formulas, whether oral or enteral, are high in carbohydrate, low in fat and fibres compared with 
DSFs which contain defined nutrient composition such as fructose, fibre, MUFA, soy bean and 
antioxidants which are designed to improve glycaemic control [19]. The source of carbohydrate in DSF 
includes increased amount of fructose relative to standard formulas and fat often in the form of higher 
amounts MUFA when compared with standard formulas although issues around tolerance on high levels 
of fats and fructose in feed have been subjects of discussion [22,35]. The main sources of fibre in DSF 
are usually fruits and vegetables and the levels are relatively higher than in standard formulas. 
Evidence of a meta-analaysis demonstrates that low GI foods have clinically more useful effect on 
medium-term glycaemic control (glycated proteins) in patients with diabetes [32]. According to 
Widanagamage et al. [36], the long-term use of foods that have high GI can place a higher metabolic 
demand on the body in terms of higher insulin requirement with the potential to lead to insulin resistance. 
5. Conclusions 
The outcomes of the studies that compared Diabetes specific formula with standard formulas appear 
to show a trend with respect to the response of glucose and other parameters such as HbA1c, which 
define diabetes. Based on the evidence in the present review, there are indications that the use of Diabetes 
specific formula could be effective in managing glucose in patients with diabetes on enteral nutrition. 
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